Identification | Back Directory | [Name]
Fraxamoside | [CAS]
326594-34-7 | [Synonyms]
Fraxamoside 2H-Pyran-4-acetic acid, 2-[[6-O-[(1R)-1-(3,4-dihydroxyphenyl)-2-hydroxyethyl]-β-D-glucopyranosyl]oxy]-3-ethylidene-3,4-dihydro-5-(methoxycarbonyl)-, intramol. 4,2''-ester, (2S,3E,4S)- | [Molecular Formula]
C25H30O13 | [MDL Number]
MFCD20261047 | [MOL File]
326594-34-7.mol | [Molecular Weight]
538.5 |
Hazard Information | Back Directory | [Description]
Fraxamoside shows significant free radical scavenging effect against DPPH(EC50=66 uM).
Fraxamoside is a xanthine oxidase inhibitor (XOI) comparable in potency in vitro to the standard antigout drug allopurinol. |
|
Company Name: |
BioBioPha Co., Ltd.
|
Tel: |
0871-65217109 13211707573; |
Website: |
http://www.biobiopha.com |
|